Association between type 2 diabetes and branched chain amino acids (BCAA); a case-control study.
Branched-chain amino acids
Dietary intake
Type 2 diabetes mellitus
Journal
Journal of diabetes and metabolic disorders
ISSN: 2251-6581
Titre abrégé: J Diabetes Metab Disord
Pays: Switzerland
ID NLM: 101590741
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
16
04
2023
accepted:
03
06
2023
pmc-release:
22
07
2024
medline:
17
11
2023
pubmed:
17
11
2023
entrez:
17
11
2023
Statut:
epublish
Résumé
Several amino acids and their derivatives have been implicated in insulin resistance (IR) and Type 2 Diabetes Mellitus (T2DM). This research sought to establish a relationship between the dietary levels of branched-chain amino acids (BCAA) and the risk of T2DM. This case-control study was carried out on 4200 participants consisting of 589 people with T2DM and 3611 non-diabetic aged 35 to 70 years residents in Sabzevar, Iran. Data on the economic-social, employment status, medical history, lifestyle, and sleep habits were collected via interview. The food frequency questionnaire (FFQ) was used to check the nutritional status. Participants' dietary BCAA consumption was estimated using Nutritionist IV software. A significant negative association between the incidence of T2DM and the dietary levels of BCAAs after adjustment for age and sex (OR = 0.972, CI 95%:0.648-0.996, P = 0.022). The negative association remained significant after additional adjustments for body mass index (BMI) and physical activity (OR = 0.967, CI 95%: 0.943-0.992, P = 0.010). Interestingly, a positive association was found between T2DM and total BCAAs (OR = 1.067, CI 95%: 1.017-1.119, P = 0.008), Isoleucine (OR = 1.248, CI 95%: 1.043-1.494, P = 0.016), Leucine (OR = 1.165, CI 95%: 1.046-1.299, P = 0.006) and Valine (OR = 1.274, CI 95%: 1.088-1.492, P = 0.003) after further adjustment for calorie intake. Our results demonstrate branched-chain amino acids (BCAAs) including isoleucine, leucine, and valine are negatively associated with the incidence of type 2 diabetes (T2DM) after adjusting for age and sex, BMI, and physical activity. However, adjusting for calorie intake reversed the association between T2DM and BCAAs. These findings suggest that the association between BCAAs and T2DM may be influenced by calorie intake. Future longitudinal studies are warranted. The online version contains supplementary material available at 10.1007/s40200-023-01247-9.
Sections du résumé
Background
UNASSIGNED
Several amino acids and their derivatives have been implicated in insulin resistance (IR) and Type 2 Diabetes Mellitus (T2DM). This research sought to establish a relationship between the dietary levels of branched-chain amino acids (BCAA) and the risk of T2DM.
Methods
UNASSIGNED
This case-control study was carried out on 4200 participants consisting of 589 people with T2DM and 3611 non-diabetic aged 35 to 70 years residents in Sabzevar, Iran. Data on the economic-social, employment status, medical history, lifestyle, and sleep habits were collected via interview. The food frequency questionnaire (FFQ) was used to check the nutritional status. Participants' dietary BCAA consumption was estimated using Nutritionist IV software.
Results
UNASSIGNED
A significant negative association between the incidence of T2DM and the dietary levels of BCAAs after adjustment for age and sex (OR = 0.972, CI 95%:0.648-0.996, P = 0.022). The negative association remained significant after additional adjustments for body mass index (BMI) and physical activity (OR = 0.967, CI 95%: 0.943-0.992, P = 0.010). Interestingly, a positive association was found between T2DM and total BCAAs (OR = 1.067, CI 95%: 1.017-1.119, P = 0.008), Isoleucine (OR = 1.248, CI 95%: 1.043-1.494, P = 0.016), Leucine (OR = 1.165, CI 95%: 1.046-1.299, P = 0.006) and Valine (OR = 1.274, CI 95%: 1.088-1.492, P = 0.003) after further adjustment for calorie intake.
Conclusions
UNASSIGNED
Our results demonstrate branched-chain amino acids (BCAAs) including isoleucine, leucine, and valine are negatively associated with the incidence of type 2 diabetes (T2DM) after adjusting for age and sex, BMI, and physical activity. However, adjusting for calorie intake reversed the association between T2DM and BCAAs. These findings suggest that the association between BCAAs and T2DM may be influenced by calorie intake. Future longitudinal studies are warranted.
Supplementary Information
UNASSIGNED
The online version contains supplementary material available at 10.1007/s40200-023-01247-9.
Identifiants
pubmed: 37975111
doi: 10.1007/s40200-023-01247-9
pii: 1247
pmc: PMC10638320
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1291-1297Informations de copyright
© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
J Nutr Biochem. 2021 Nov;97:108811
pubmed: 34197915
Nutrients. 2016 Jul 01;8(7):
pubmed: 27376324
Sci Rep. 2016 Feb 05;6:20594
pubmed: 26846565
Metab Syndr Relat Disord. 2015 Jun;13(5):195-202
pubmed: 25664967
J Diabetes. 2018 May;10(5):350-352
pubmed: 29369529
Circ Res. 2016 May 27;118(11):1752-70
pubmed: 27230640
DNA Cell Biol. 2016 Jan;35(1):1-12
pubmed: 26495765
J Nutr. 2003 Jan;133(1):261S-267S
pubmed: 12514305
Diabetes Care. 2014 Jul;37(7):1854-62
pubmed: 24722499
Am J Clin Nutr. 2011 Dec;94(6):1600-6
pubmed: 22071707
Metabolomics. 2016 Jan;12:
pubmed: 27840598
Diabetes Care. 2016 Apr;39(4):582-8
pubmed: 26895884
Am J Epidemiol. 2016 Apr 15;183(8):715-28
pubmed: 27022032
Diabetes Care. 2017 Dec;40(12):1779-1786
pubmed: 29046328
Nat Rev Endocrinol. 2014 Dec;10(12):723-36
pubmed: 25287287
Amino Acids. 2012 Jul;43(1):171-81
pubmed: 21984377
Cell Metab. 2012 May 2;15(5):606-14
pubmed: 22560213
PLoS One. 2010 Dec 10;5(12):e15234
pubmed: 21170321
Int J Epidemiol. 2016 Oct;45(5):1482-1492
pubmed: 27413102
Metabolism. 2015 Feb;64(2):253-62
pubmed: 25458830
Diabetes Care. 2013 Jul;36(7):2001-8
pubmed: 23378620
Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):65-71
pubmed: 28539866
J Diabetes Res. 2016;2016:3898502
pubmed: 26636104
J Clin Med. 2018 Dec 04;7(12):
pubmed: 30518023
Nutrients. 2020 Dec 30;13(1):
pubmed: 33396718
Diabetes Res Clin Pract. 2017 Oct;132:45-58
pubmed: 28783532
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
Br J Nutr. 2018 Apr;119(8):910-917
pubmed: 29644957
Int J Endocrinol. 2016;2016:8173905
pubmed: 27528871
Public Health Nutr. 2014 Jul;17(7):1587-94
pubmed: 23866795
Annu Rev Nutr. 2007;27:293-310
pubmed: 17666010
Diabetes Care. 2013 Mar;36(3):648-55
pubmed: 23129134
Nat Med. 2011 Apr;17(4):448-53
pubmed: 21423183
Diabetes. 2007 Jun;56(6):1647-54
pubmed: 17360978
Diabetes. 2002 Mar;51(3):599-605
pubmed: 11872656
Diabetes Care. 2016 May;39(5):833-46
pubmed: 27208380
Br J Nutr. 2013 Mar 28;109(6):1143-53
pubmed: 22850191
Am J Epidemiol. 2013 Oct 15;178(8):1226-32
pubmed: 24008908
Front Med (Lausanne). 2016 Nov 25;3:57
pubmed: 27933294
PLoS Med. 2016 Nov 29;13(11):e1002179
pubmed: 27898682